Clinical trial · Observational
Depiction of Prostate Cancer Treatment Alternatives in Greece
NCT00733213CI-TRIAL-00002700completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A retrospective, registry analysis of the socio-economic and demographic characteristics of patients suffering from locally advanced or metastatic prostate cancer, as well as the depiction of the therapeutic algorithms followed in the Greek clinical practice. * Target Group: Patients with locally advanced or metastatic prostate cancer. * The first 10 consecutive patients records that meet the entry criteria.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Locally Advanced or Metastatic Prostate Cancer. | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Percentage of patients treated by each treatment alternative.
- timeFrame
- Between 2002 - 2008
Secondary outcomes (1)
- measure
- To depict sociodemographic characteristics and comorbidities.
- timeFrame
- Between 2002 - 2008
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients diagnosed with Locally advanced or Metastatic Prostate Cancer after 2002. * Patients that received Hormonal therapy. Exclusion Criteria: * Males that are aged less than 18 years
References
Publications (0)
Data not yet available
No reference posted for this study.